Regenerative medicine company Avita Medical is seeking to raise up to $40 million to fund its American launch and for research and development.
Stockbroker Bell Potter Securities was in the market offering new shares at 8.2¢ each on Friday, which was a 2.4 per cent discount to the last close and a 14.4 per cent discount to the 30-day volume weighted average price, according to terms sent to potential investors.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
